These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
81 related items for PubMed ID: 454928
1. Agonist interactions with [3H]-spiperone binding sites on rat corpus striatum membranes [proceedings]. Howlett DR, Morris H, Nahorski SR. Br J Pharmacol; 1979 May; 66(1):136P. PubMed ID: 454928 [No Abstract] [Full Text] [Related]
2. Analysis of dopamine interactions with [3H]-spiperone binding sites on rat corpus striatum membranes [proceedings]. Howlett DR, Nahorski SR. Br J Pharmacol; 1979 Jul; 66(3):468P-469P. PubMed ID: 526752 [No Abstract] [Full Text] [Related]
4. Effects of chronic haloperidol, thioridazine and zotepine treatment on apomorphine elicited stereotypic behavior and 3H-spiroperidol binding sites in the striatum of the rat. Lai HC, Carino MA, Horita A. Proc West Pharmacol Soc; 1981 Dec; 24():5-6. PubMed ID: 6114496 [No Abstract] [Full Text] [Related]
5. Anomalous properties of [3H]spiperone binding sites in various areas of the rat limbic system. Howlett DR, Morris H, Nahorski SR. Mol Pharmacol; 1979 May; 15(3):506-14. PubMed ID: 492143 [No Abstract] [Full Text] [Related]
6. [3H]spiperone binding sites in rat primary glial cultures, C6 glioma, and B104 neuroblastoma. Severson JA, de Vellis JS, Finch CE. J Neurosci Res; 1983 May; 9(1):21-6. PubMed ID: 6834436 [Abstract] [Full Text] [Related]
7. Comparison of dopamine receptor sites labeled by [3H]-S-sulpiride and [3H]-spiperone in striatum. Zahniser NR, Dubocovich ML. J Pharmacol Exp Ther; 1983 Dec; 227(3):592-9. PubMed ID: 6655559 [Abstract] [Full Text] [Related]
8. Modulation by cholecystokinins of 3H-spiroperidol binding in rat striatum: evidence for increased affinity and reduction in the number of binding sites. Fuxe K, Agnati LF, Benfenati F, Cimmino M, Algeri S, Hökfelt T, Mutt V. Acta Physiol Scand; 1981 Dec; 113(4):567-9. PubMed ID: 6291324 [No Abstract] [Full Text] [Related]
9. Two binding sites for 3H-spiroperidol on rat striatal membranes. Briley M, Langer SZ. Eur J Pharmacol; 1978 Aug 01; 50(3):283-4. PubMed ID: 28956 [No Abstract] [Full Text] [Related]
10. Antagonism by supidimide of haloperidol-induced augmentation of [3H]-spiperone binding in rat striatum. Hennies HH, Hess V, Flohé L. Arzneimittelforschung; 1984 Aug 01; 34(11):1481-4. PubMed ID: 6543122 [Abstract] [Full Text] [Related]
11. Lisuride inhibits 3H-spiroperidol binding to membranes isolated from striatum. Fujita N, Saito K, Yonehara N, Yoshida H. Neuropharmacology; 1978 Dec 01; 17(12):1089-91. PubMed ID: 745698 [No Abstract] [Full Text] [Related]
12. [Relation between brain D2-dopamine receptors and 3H-spiperone binding sites of intact lymphocytes]. Noguchi-kuno SA, Nakata C, Nishitani H. Rinsho Shinkeigaku; 1983 Sep 01; 23(9):814-8. PubMed ID: 6232031 [No Abstract] [Full Text] [Related]
15. Chronic sulpiride increased 3H-spiperone binding and calmodulin dependent phosphorylation in rat striatum. Lau YS, Runice C, Dowd FJ, Anene C. Proc West Pharmacol Soc; 1983 Sep 01; 26():139-43. PubMed ID: 6310625 [No Abstract] [Full Text] [Related]
16. The in vivo and in vitro occupation of [3H]-spiperone binding sites in the frontal cortex and striatum by putative 5-hydroxytryptamine antagonists. Clements-Jewery S, Robson PA. Neuropharmacology; 1980 Jul 01; 19(7):657-61. PubMed ID: 7402453 [No Abstract] [Full Text] [Related]
17. 3H-Spiroperidol binding to two receptor sites in both the corpus striatum and frontal cortex of rat brain. Pedigo NW, Reisine TD, Fields JZ, Yamamura HI. Eur J Pharmacol; 1978 Aug 15; 50(4):451-3. PubMed ID: 699968 [No Abstract] [Full Text] [Related]
19. Dopamine denervation does not alter in vivo 3H-spiperone binding in rat striatum: implications for external imaging of dopamine receptors in Parkinson's disease. Bennett JP, Wooten GF. Ann Neurol; 1986 Apr 15; 19(4):378-83. PubMed ID: 3707090 [Abstract] [Full Text] [Related]
20. Distinctions between ligand-binding sites for [3H]dopamine and D2 dopaminergic receptors characterized with [3H]spiroperidol. Hancock AA, Marsh CL. Mol Pharmacol; 1984 Nov 15; 26(3):439-51. PubMed ID: 6238230 [Abstract] [Full Text] [Related] Page: [Next] [New Search]